formoterol

Known as: Formoterol [Chemical/Ingredient], Eformoterol, 2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide 
A long-acting beta-adrenergic receptor agonist with bronchodilator activity. Formoterol selectively binds to beta-2 adrenergic receptors in bronchial… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1981-2017
05010019812017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
RATIONALE Budesonide/formoterol and tiotropium are commonly used maintenance treatments for patients with chronic obstructive… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The contributions of as-needed inhaled corticosteroids and long-acting beta2 agonists (LABA) to asthma control have… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The combination of short-acting beta(2)-agonists and anticholinergics in the treatment of COPD has been well… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Asthma control is improved by combining inhaled corticosteroids with long-acting beta2-agonists. However, fluctuating asthma… (More)
  • table 1
  • figure 2
  • figure 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
This study compared the bronchodilator effects of tiotropium, formoterol and both combined in chronic obstructive pulmonary… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
The efficacy and safety of budesonide/formoterol in a single inhaler compared with placebo, budesonide and formoterol were… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Lung function in chronic obstructive pulmonary disease (COPD) can be improved acutely by oral corticosteroids and bronchodilators… (More)
  • table 1
  • table 2
  • figure 2
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The optimal treatment for mild asthma is uncertain. We assessed the effects of adding a long-acting inhaled beta-agonist… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
We compared the effectiveness of inhaled formoterol with that of ipratropium in the treatment of chronic obstructive pulmonary… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND The role of long-acting, inhaled beta2-agonists in treating asthma is uncertain. In a double-blind study, we evaluated… (More)
Is this relevant?